The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
6,122
Sort by:
North America: Vitamins Market
US$ 1,999.00
... report on the vitamins market in North America covers the following countries: Canada, Mexico, and the United States of America. The report on the vitamins market in North America includes: Analysis and ...
February 2021
150 pages
Antibiotics Market Research Report by Drug Class (Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, and Macrolides), by Action Mechanism (Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors) - Global Forecast to 2025 - Cumulative Impact of COVID-19
US$ 3,949.00
Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...
February 2021
193 pages
Antidiabetic Drug Market Research Report by Type (Alpha-glucosidase Inhibitors, Biguanides, DPP-IV (Dipeptidyl Peptidase) Inhibitors, GLP-1 (Glucagon-like Peptide) Agonists, and Insulin), by Disease (Diabetes Mellitus Type 1 and Diabetes Mellitus Type 2), by Patient - Global Forecast to 2025 - Cumulative Impact of COVID-19
US$ 3,949.00
Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...
February 2021
194 pages
Hormonal Contraceptives Market Research Report by Hormone Type (Androgens, Antiandrogens, Estrogens, Gonadotropins, and Progestogens), by Method Type (Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, and Oral Contraceptives), by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19
US$ 3,949.00
Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...
February 2021
198 pages
Ophthalmic Drugs Market Size, Share & Trends Analysis Report By Disease (Dry Eye, Eye Allergy, Glaucoma, Eye Infection), By Drug Class, By Dosage Form, By Route Of Administration, By Product Type, By Region, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
The global ophthalmic therapeutics/drugs market is expected to reach USD 35.7 billion by 2025, according to a new report by Grand ... the presence of strong emerging pipeline drugs are some of the factors responsible for the growth of ophthalmic therapeutics market. For instance, the recent approval ...
February 2021
307 pages
Antibiotics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-ACA), By Action Mechanism, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
The global antibiotics market size is expected to reach USD 62.06 billion by 2025 expanding at a CAGR of 4.0%, according to a new ... . Government reforms specific to antibiotics, such as the Generating Antibiotics Incentives Now (GAIN) Act in U.S., are projected to help boost the market growth over the ...
February 2021
120 pages
Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow (Lead Identification & Candidate Optimization, Others), By Therapeutics Area (Oncology, Respiratory System), By Drug Type, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
... drug discovery outsourcing market size is expected to reach USD 4.44 billion by 2025 at an 8.14% CAGR, according to a new report by Grand View Research, Inc. Urging need to identify potential drug ...
February 2021
128 pages
Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2021
US$ 1,500.00
... chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chemotherapy Induced Nausea and Vomiting The report also ...
February 2021
80 pages
Gallbladder cancer - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Gallbladder Cancer - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Gallbladder Cancer development. The report provides ...
February 2021
60 pages
Yellow Fever- Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Yellow Fever - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Yellow Fever development. The report provides ...
February 2021
60 pages
End-Stage Renal Disease - Pipeline Insight, 2021
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for End-Stage Kidney Disease The report also covers ...
February 2021
60 pages
Non-Small-Cell Lung Carcinoma (NSCLC) - Pipeline Insight, 2021
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Non-Small Cell Lung Cancer The report also ...
February 2021
60 pages
Glycogen Synthase Kinase 3 (GSK3) inhibitor - Pipeline Insight, 2021
US$ 1,500.00
... limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “Glycogen Synthase Kinase 3 (GSK-3) Inhibitor The report ...
February 2021
60 pages
LAG-3 Antagonist - Pipeline Insight, 2021
US$ 2,000.00
... drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “LAG-3 Antagonist The report assesses the active LAG-3 Antagonist ...
February 2021
70 pages
Lipoxygenase Inhibitors - Pipeline Insight, 2021
US$ 1,500.00
... not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “Lipoxygenase Inhibitor (LOX Inhibitor) The report ...
February 2021
80 pages
Mitogen Activated Protein Kinase Kinase 2 inhibitors - Pipeline Insight, 2021
US$ 1,500.00
... , product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor The ...
February 2021
60 pages
Polo-Like Kinase 1 (PLK1) Inhibitor - Pipeline Insight, 2021
US$ 1,500.00
... (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “Polo-Like Kinase 1 (PLK1 )Inhibitor The report ...
February 2021
60 pages
Atrial Fibrillation - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Atrial Fibrillation - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeli...
February 2021
60 pages
Graves Ophthalmopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Graves Ophthalmopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipe...
February 2021
60 pages
IgA Nephropathy- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “IgA Nephropathy – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline...
February 2021
60 pages
MALT Lymhoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Mucosa-associated Lymphoid Tissue (MALT) Lymphoma – Pipeline Insight, 2021,” report provides comprehensive insights ab...
February 2021
60 pages
Mild To Moderate Plaque Psoriasis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Mild To Moderate Plaque Psoriasis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies...
February 2021
60 pages
Postoperative pain - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “Postoperative pain - Pipeline Insight, 2021,” report provides comprehensive insights about 60+ companies and 60+...
February 2021
200 pages
ACALABRUTINIB - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ACALABRUTINIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product...
February 2021
30 pages
Aliqopa - Drug Insight and Market Forecast - 2030
US$ 2,750.00
This report can be delivered to the clients within 48 Hours OVERVIEW “Aliqopa - Drug Insight and Market Forecast - 2030” report by DelveInsight outlays comprehensive insights of the product indicate...
February 2021
30 pages
ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product fo...
February 2021
30 pages
ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product f...
February 2021
30 pages
BI 764524 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “BI 764524 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
BLINATUMOMAB - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “BLINATUMOMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product f...
February 2021
30 pages
DB-102 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “DB-102 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Dif...
February 2021
30 pages
RG 7774 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “RG 7774 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Di...
February 2021
30 pages
TREAKISYM - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “TREAKISYM - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
VENGLUSTAT - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “VENGLUSTAT - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
Zydelig - Drug Insight and Market Forecast - 2030
US$ 2,750.00
This report can be delivered to the clients within 48 Hours OVERVIEW “Zydelig - Drug Insight and Market Forecast - 2030” report by DelveInsight outlays comprehensive insights of the product indicate...
February 2021
30 pages
Abnormal Glucose tolerance-Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Abnormal Glucose Tolerance – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+...
February 2021
60 pages
Advanced Urotheilal carcinoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Advanced Urothelial Carcinoma – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies an...
February 2021
60 pages
Alpha Thalassemia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Alpha Thalassemia – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline...
February 2021
60 pages
